Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081655 | SCV000113586 | benign | not specified | 2014-09-09 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081655 | SCV000195486 | benign | not specified | 2017-10-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081655 | SCV000209394 | benign | not specified | 2018-03-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Pediatric Genomic Medicine, |
RCV000167557 | SCV000511722 | benign | not provided | 2017-01-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000159447 | SCV000555865 | likely benign | Mowat-Wilson syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000159447 | SCV000782425 | likely benign | Mowat-Wilson syndrome | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000167557 | SCV000844914 | benign | not provided | 2016-07-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313792 | SCV000847375 | benign | Inborn genetic diseases | 2016-06-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Centre for Mendelian Genomics, |
RCV000159447 | SCV001370192 | likely benign | Mowat-Wilson syndrome | 2019-03-06 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely benign. The following ACMG criteria were applied in classifying this variant: BP1,BP6. |
Genome- |
RCV000159447 | SCV002045689 | benign | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000159447 | SCV002799055 | likely benign | Mowat-Wilson syndrome | 2021-07-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000167557 | SCV004011195 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | ZEB2: BP4, BS1 |
Breakthrough Genomics, |
RCV000167557 | SCV005255788 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genomic Diagnostic Laboratory, |
RCV000167557 | SCV000218437 | likely benign | not provided | 2015-01-30 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000167557 | SCV001927915 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000167557 | SCV001966190 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925072 | SCV004743182 | likely benign | ZEB2-related disorder | 2019-12-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |